-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ju5059wTkL/hhtUa4Su58f3dh08vX5YDjErON1WdaHACdf8aqJNDEzBRrrf8dU1c wPFOT3scZlDzRgK1mWe/wg== 0000064670-06-000069.txt : 20061101 0000064670-06-000069.hdr.sgml : 20061101 20061101180926 ACCESSION NUMBER: 0000064670-06-000069 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061030 FILED AS OF DATE: 20061101 DATE AS OF CHANGE: 20061101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDTRONIC INC CENTRAL INDEX KEY: 0000064670 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 410793183 STATE OF INCORPORATION: MN FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 710 MEDTRONIC PKWY STREET 2: MS LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 BUSINESS PHONE: 7635144000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ellis Gary Lee CENTRAL INDEX KEY: 0001290170 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07707 FILM NUMBER: 061180138 BUSINESS ADDRESS: BUSINESS PHONE: 763-514-4000 MAIL ADDRESS: STREET 1: MEDTRONIC, INC. STREET 2: 710 MEDTRONIC PARKWAY CITY: MINNEAPOLIS STATE: MN ZIP: 55432 4 1 doc.xml PRIMARY DOCUMENT X0202 4 2006-10-30 0000064670 MEDTRONIC INC MDT 0001290170 Ellis Gary Lee MEDTRONIC, INC. 710 MEDTRONIC PARKWAY, M.S. LC310 MINNEAPOLIS MN 55432-5604 0 1 0 0 Sr VP & CFO Common Stock 2006-10-30 4 A 0 11294 0 A 52634.367 D Common Stock 3864.623 I By 401(k) Plan Common Stock 6493.083 I By ESOP Stock Options (Right to buy) 48.7 2006-10-30 4 A 0 41068 0 A 2007-10-30 2016-10-30 Common Stock 41068 41068 D This balance increased by 20.356 due to exempt dividend reinvestment and dividend equivalent transactions. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. The restrictions on this restricted stock award shall lapse on the third anniversary of the grant date if the Company's cumulative earnings growth during the three year period ending on the last day of fiscal year 2009 equals or exceeds a 9% compound annual growth rate, as determined by the Compensation Committee. In the circumstances of death, Disability or Retirement, these restrictions shall lapse on a pro-rata basis, provided that the mimimum threshhold has been achieved through fiscal 2009. Keyna P. Skeffington, Attorney-in-Fact 2006-11-01 -----END PRIVACY-ENHANCED MESSAGE-----